Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M |
| Total Depreciation and Amortization | 683.00K | 653.00K | 604.00K | 529.00K | 615.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.48M | 4.12M | 14.55M | 6.54M | 1.21M |
| Change in Net Operating Assets | 317.00K | -1.50M | -6.47M | -3.24M | -1.71M |
| Cash from Operations | -8.73M | -13.59M | -19.98M | -14.28M | -9.61M |
| Capital Expenditure | -1.28M | -1.78M | -333.00K | -561.00K | -1.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.77M | 7.95M | -178.79M | -29.10M | 17.16M |
| Cash from Investing | 9.49M | 6.17M | -179.12M | -29.66M | 15.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.65M | 42.00K | 211.12M | 38.00K | 46.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 59.66M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -2.81M | -1.22M |
| Cash from Financing | 2.65M | 42.00K | 211.12M | 56.89M | -1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.41M | -7.38M | 12.02M | 12.95M | 4.45M |